These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
213 related items for PubMed ID: 31779275
1. Ribosome-Inactivating Protein α-Momorcharin Derived from Edible Plant Momordica charantia Induces Inflammatory Responses by Activating the NF-kappaB and JNK Pathways. Chen YJ, Zhu JQ, Fu XQ, Su T, Li T, Guo H, Zhu PL, Lee SK, Yu H, Tse AK, Yu ZL. Toxins (Basel); 2019 Nov 26; 11(12):. PubMed ID: 31779275 [Abstract] [Full Text] [Related]
2. Preparation of an antitumor and antivirus agent: chemical modification of α-MMC and MAP30 from Momordica Charantia L. with covalent conjugation of polyethyelene glycol. Meng Y, Liu S, Li J, Meng Y, Zhao X. Int J Nanomedicine; 2012 Nov 26; 7():3133-42. PubMed ID: 22802682 [Abstract] [Full Text] [Related]
3. Alpha-momorcharin (α-MMC) exerts effective anti-human breast tumor activities but has a narrow therapeutic window in vivo. Cao D, Sun Y, Wang L, He Q, Zheng J, Deng F, Deng S, Chang S, Yu X, Li M, Meng Y, Jin J, Shen F. Fitoterapia; 2015 Jan 26; 100():139-49. PubMed ID: 25447153 [Abstract] [Full Text] [Related]
4. Immunoaffinity purification of α-momorcharin from bitter melon seeds (Momordica charantia). Yao X, Li J, Deng N, Wang S, Meng Y, Shen F. J Sep Sci; 2011 Nov 26; 34(21):3092-8. PubMed ID: 21994203 [Abstract] [Full Text] [Related]
5. Alpha-momorcharin, a RIP produced by bitter melon, enhances defense response in tobacco plants against diverse plant viruses and shows antifungal activity in vitro. Zhu F, Zhang P, Meng YF, Xu F, Zhang DW, Cheng J, Lin HH, Xi DH. Planta; 2013 Jan 26; 237(1):77-88. PubMed ID: 22983699 [Abstract] [Full Text] [Related]
6. Alpha-momorcharin regulates cytokine expression and induces apoptosis in monocytes. Deng N, Sun Y, Liu M, He Q, Wang L, Zhang Y, Sun W, Lei N, Liu Y, Luo Y, Shen F. Immunopharmacol Immunotoxicol; 2019 Apr 26; 41(2):258-266. PubMed ID: 31062632 [Abstract] [Full Text] [Related]
7. Alpha-momorcharin possessing high immunogenicity, immunotoxicity and hepatotoxicity in SD rats. Meng Y, Liu B, Lei N, Zheng J, He Q, Li D, Zhao X, Shen F. J Ethnopharmacol; 2012 Jan 31; 139(2):590-8. PubMed ID: 22172326 [Abstract] [Full Text] [Related]
8. Atomic-resolution structures of type I ribosome inactivating protein alpha-momorcharin with different substrate analogs. Fan X, Wang Y, Guo F, Zhang Y, Jin T. Int J Biol Macromol; 2020 Dec 01; 164():265-276. PubMed ID: 32653369 [Abstract] [Full Text] [Related]
9. A novel method for simultaneous production of two ribosome-inactivating proteins, α-MMC and MAP30, from Momordica charantia L. Meng Y, Lin S, Liu S, Fan X, Li G, Meng Y. PLoS One; 2014 Dec 01; 9(7):e101998. PubMed ID: 25003606 [Abstract] [Full Text] [Related]
10. Molecular cloning and functional analysis of a recombinant ribosome-inactivating protein (alpha-momorcharin) from Momordica charantia. Wang S, Zhang Y, Liu H, He Y, Yan J, Wu Z, Ding Y. Appl Microbiol Biotechnol; 2012 Nov 01; 96(4):939-50. PubMed ID: 22262229 [Abstract] [Full Text] [Related]
12. Preferential cytotoxicity of the type I ribosome inactivating protein alpha-momorcharin on human nasopharyngeal carcinoma cells under normoxia and hypoxia. Pan WL, Wong JH, Fang EF, Chan YS, Ng TB, Cheung RC. Biochem Pharmacol; 2014 Jun 01; 89(3):329-39. PubMed ID: 24637239 [Abstract] [Full Text] [Related]
13. Cytotoxicity mechanism of α-MMC in normal liver cells through LRP1 mediated endocytosis and JNK activation. Wang L, Shen F, Zhang M, He Q, Zhao H, Yu X, Yang S, Liu Y, Deng N, Zheng J, Zhu L, Liu X. Toxicology; 2016 May 16; 357-358():33-43. PubMed ID: 27262837 [Abstract] [Full Text] [Related]
14. PEGylation is effective in reducing immunogenicity, immunotoxicity, and hepatotoxicity of α-momorcharin in vivo. Zheng JC, Lei N, He QC, Hu W, Jin JG, Meng Y, Deng NH, Meng YF, Zhang CJ, Shen FB. Immunopharmacol Immunotoxicol; 2012 Oct 16; 34(5):866-73. PubMed ID: 22439816 [Abstract] [Full Text] [Related]
15. Ribosome inactivating proteins (RIPs) from Momordica charantia for anti viral therapy. Puri M, Kaur I, Kanwar RK, Gupta RC, Chauhan A, Kanwar JR. Curr Mol Med; 2009 Dec 16; 9(9):1080-94. PubMed ID: 19747115 [Abstract] [Full Text] [Related]
16. BG-4, a novel bioactive peptide from momordica charantia, inhibits lipopolysaccharide-induced inflammation in THP-1 human macrophages. Jones LD, Pangloli P, Krishnan HB, Dia VP. Phytomedicine; 2018 Mar 15; 42():226-232. PubMed ID: 29655690 [Abstract] [Full Text] [Related]
17. Ribosome-inactivating proteins isolated from dietary bitter melon induce apoptosis and inhibit histone deacetylase-1 selectively in premalignant and malignant prostate cancer cells. Xiong SD, Yu K, Liu XH, Yin LH, Kirschenbaum A, Yao S, Narla G, DiFeo A, Wu JB, Yuan Y, Ho SM, Lam YW, Levine AC. Int J Cancer; 2009 Aug 15; 125(4):774-82. PubMed ID: 19384952 [Abstract] [Full Text] [Related]
18. Alpha-momorcharin: a ribosome-inactivating protein from Momordica charantia, possessing DNA cleavage properties. Wang S, Zheng Y, Yan J, Zhu Z, Wu Z, Ding Y. Protein Pept Lett; 2013 Nov 15; 20(11):1257-63. PubMed ID: 23777339 [Abstract] [Full Text] [Related]
19. The Roles of Alpha-Momorcharin and Jasmonic Acid in Modulating the Response of Momordica charantia to Cucumber Mosaic Virus. Yang T, Meng Y, Chen LJ, Lin HH, Xi DH. Front Microbiol; 2016 Nov 15; 7():1796. PubMed ID: 27881976 [Abstract] [Full Text] [Related]
20. TNF-α Drives the CCL4 Expression in Human Monocytic Cells: Involvement of the SAPK/JNK and NF-κB Signaling Pathways. Ahmad R, Kochumon S, Chandy B, Shenouda S, Koshy M, Hasan A, Arefanian H, Al-Mulla F, Sindhu S. Cell Physiol Biochem; 2019 Nov 15; 52(4):908-921. PubMed ID: 30964608 [Abstract] [Full Text] [Related] Page: [Next] [New Search]